JOSE LATORRE: Open Payments
NPI 1790785640 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,572 in 169 payments from 28 companies in 2025. Trend: 2023 $2,499 · 2024 $3,896 · 2025 $4,572
Food & beverage: $4,572
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $573 |
| AstraZeneca Pharmaceuticals LP | 20 | $557 |
| ViiV Healthcare Company | 17 | $489 |
| Lilly USA, LLC | 12 | $384 |
| Gilead Sciences, Inc. | 21 | $365 |
| Corcept Therapeutics | 6 | $261 |
| Astellas Pharma US Inc | 8 | $220 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $185 |
| ABBVIE INC. | 8 | $182 |
| Ardelyx, Inc. | 9 | $166 |
Products named: Ozempic, DOVATO, FARXIGA, JARDIANCE, Korlym, Veozah, Kerendia, IBSRELA.
Industry payments across CT — which companies pay providers there.
